Skip to main content

Table 3 Treatment response on days 3 and 7

From: Use of cefepime, meropenem, or piperacillin/tazobactam as initial treatment for febrile neutropenia in patients with hematological malignancy — a real-life experience

Response

Cefepime

Meropenem

Piperacillin/tazobactum

p-valuea

p-valueb

p-valuec

Day 3

20/33 (60.61)

21/33 (63.64)

17/33 (51.52)

0.800

0.319

0.457

Day 7

21/33 (63.64)

25/33 (75.76)

22/33 (66.67)

0.284

0.415

0.796

  1. aCefepime vs meropenem, bmeropenem vs piperacillin/tazobactam, ccefepime vs piperacillin/tazobactam